Combining Default Choices and a Decision Aid to Improve Tobacco Cessation

clipboard-pencil

About the study

The FIRST cluster randomized trial will evaluate the effect of 1) a training program encouraging general practitioners to offer smoking cessation treatment as a default choice to all current smokers consulting a general practitioner (GP), and 2) an interactive, electronic decision aid to guide smoking cessation treatment, on the proportion of current smokers seen in primary care who have quit smoking 6 months after a baseline visit to their GP, as compared to enhanced usual care.
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

Patient-level inclusion criteria:


  1. Consider the GP they are seeing in consultation to be their primary care doctor
  2. Use tobacco daily (cigarettes, cigars, smokeless tobacco)
  3. ≥18 years of age at the time of inclusion

GP-level inclusion criteria:


  1. GP in private practice in French-speaking Switzerland (Vaud, Geneva, Jura, Neuchâtel, Fribourg or Valais) or metropolitan France
  2. Primarily French-speaking patients with >80 individual patients seen in a typical month

EXCLUSION CRITERIA

Patient-level exclusion criteria:


  1. Consulting for an urgent complaint that precludes even a brief discussion of smoking cessation
  2. Inability to follow the procedures of the study, e.g. unable to read French-language consent materials, severe psychiatric disorders, dementia, etc.
  3. Previous enrolment in a smoking cessation trial <1 year prior
  4. Current daily user of a pharmacologic smoking cessation aid

GP-level exclusion criteria:


  1. Completed an intensive smoking cessation curriculum <2 years prior (ie. at least half-day of training)
  2. Have plans to retire or relocate outside of Switzerland or France in <12 months

pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.

Study’s details


Contition
Smoking Cessation
Age (in years)
18+
Phase
Not Applicable
Participants needed
287
Est. Completion Date
Dec 31, 2023
Treatment type
Interventional

Sponsor
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
ClinicalTrials.gov identifier
NCT04868474
Study number
FIRST

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.